MedTrace Logo

Treatment of Moderate FMR During AVR

NCT05566340 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2022-10-04

No results posted yet for this study

Summary

Debates exist on the treatment of moderate functional mitral regurgitation (FMR) in patients undergoing aortic valve replacement (AVR) for aortic valve disease. This study aims to evaluate the left ventricular function, which was evaluated through global longitudinal strain, after isolated AVR and AVR + mitral valve repair (MVr) in this group of patients.

Conditions

  • Functional Mitral Regurgitation

Interventions

PROCEDURE

mitral valve repair

Repair of mitral valve concomitant to aortic valve replacement.

Sponsors & Collaborators

  • Fuwai Yunnan Cardiovascular Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-10-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05566340 on ClinicalTrials.gov